Metabolic effects of continuous veno-venous haemofiltration in critically ill patients. 1994

P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
Department of Anesthesiology and Critical Care, Tel Aviv Medical Center, Ichilov Hospital, Israel.

OBJECTIVE To evaluate the short-term metabolic and haemodynamic effects of continuous veno-venous haemofiltration (CVVH) in critically ill patients with acute renal failure (ARF). METHODS Prospective study of nine consecutive critically ill patients with established acute oliguric renal failure. METHODS A general ICU in an 800-bed university hospital. METHODS Critically ill patients, mean age 56 +/- 6 years. Four had multi-organ failure, one had acute haemolytic uraemic syndrome, one had idiopathic lactic acidosis, two had haemorrhagic pancreatitis and one had urinary sepsis. METHODS All patients were mechanically ventilated with arterial and pulmonary artery catheters in situ. RESULTS Oxygen consumption (VO2), CO2 production (VCO2) resting energy expenditure (REE), continuous blood pressure, heart rate, central venous pressure (CVP), pulmonary artery pressure (PAP), and cardiac output (CO), as well as tidal and minute volumes, end-tidal CO2 and arterial blood gases, were continuously measured for one hour prior to and one hour following the institution of CVVH. Body temperature, arterial blood pressure, heart rate, CVP and pulmonary artery catheter data remained stable throughout the study period. Prior to CVVH, VO2 was 326 +/- 33 ml/min, VCO2 was 245 +/- 27 ml/min and REE was 2241 +/- 231 kcal/24 hours. Following institution of CVVH, VO2 was 324 +/- 33 ml/min, VCO2 was 244 +/- 27 ml/min and REE was 2227 +/- 230 kcal/24 hours. CONCLUSIONS CVVH does not affect metabolic rate and haemodynamic stability in critically ill patients. The lack of any effect on the metabolic rate and haemodynamic parameters in such patients may have significant clinical importance and it further attests to the suitability of CVVH for the treatment of critically ill patients.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
June 1996, Anaesthesia,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
March 2003, The Journal of antimicrobial chemotherapy,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
February 2001, The Journal of antimicrobial chemotherapy,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
September 2017, Clinical pharmacokinetics,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
January 2004, International journal of antimicrobial agents,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
January 1999, Critical care (London, England),
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
May 2022, British journal of clinical pharmacology,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
January 2000, Nursing in critical care,
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
June 2010, Zhonghua wai ke za zhi [Chinese journal of surgery],
P Sorkine, and P Halpern, and A Scarlat, and A Weinbroum, and A Silbiger, and A Setton, and V Rudick
April 2010, International journal of clinical pharmacology and therapeutics,
Copied contents to your clipboard!